Andere talen Osteopore Limited

Aandelen

Vertraagde tijd Australian S.E. Andere beurzen 02:13:04 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,33 ^AUD	0,00%		-16,46%	-50,00%

23/04	Australische aandelen stijgen op groei bedrijfsactiviteit; Osteopore stijgt 127%	MT
29/02	Osteopore Limited rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Australian Shares Rise on Business Activity Growth; Osteopore Soars 127%	23/04
Osteopore Commences In-Human Clinical Trials for Knee Preservation; Shares Surge 194%	23/04
Osteopore Secures Extension for Bridging Loan Maturity	10/04
Osteopore Achieves 97% Take Up on Entitlement Offer to Raise AU$2.9 Million	05/04
Osteopore Secures Singapore, Vietnam Market Approvals for Orthopedic Products	26/03
Osteopore Completes Clinical Trial of Customized Scaffolds for Bone Reconstruction	26/03
Osteopore Consolidates Capital	04/03
Osteopore Limited Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Slowing Domestic Inflation Buoy Australian Shares to Eight-Day Winning Streak	31/01
Osteopore Posts 61% Jump in Q4 Revenue; Shares Rise 6%	31/01
Osteopore Surpasses Sales of 100,000 Implants Globally	29/01
Osteopore Enters Bridging Loan Agreement with Advance Opportunities Fund I	29/12
Osteopore Limited announced that it expects to receive SGD 1 million in funding	28/12
Osteopore Secures Clearance to Supply Neurosurgery Products to Hainan, China	18/12
Osteopore in Talks to Distribute Products in China	13-09-23
Osteopore Limited Announces Resignation of Deborah Ho as Joint Company Secretary	04-09-23
Osteopore Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31-08-23
Osteopore Signs Deal to Commercialize Products in China; Shares Rise 4%	25-07-23
Osteopore Promotes Operating, Technology Chief to CEO	18-07-23
Osteopore Limited Announces Executive Changes	18-07-23

Geen resultaten voor deze zoekopdracht